(1)
Taniwaki, M.; Yoshida, M.; Matsumoto, Y.; Shimura, K.; Kuroda, J.; Kaneko, H. ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING. Mediterr J Hematol Infect Dis 2018, 10, e2018014.